email    contact

平成22年2010年から

3月 日本循環器学会
(京都)
3月 日本薬理学会
(大阪)

5月 日本生理学会
(盛岡)
出展

MRI下で、
血圧モニター
心拍数 
が連続監視できます。


研究用

CareTaker  ワイヤレス 連続
非観血血圧
血圧波 血圧値計
研究用、実験用、学術用、臨床以外

発売元 メディカルテクニカ有限会社

Medical Teknika Medical Teknika Medical Teknika Medical Teknika Medical Teknika
Medical Teknika Medical Teknika Medical Teknika Medical Teknika Medical Teknika
Medical Teknika

PCの機能が向上し、Descrete Wavelet 手法が、お求めやすい低価格で

実現し、心房のP波を自動検出できるようになりました、

心房細動の自動解析能をお試し賜われれば幸いです


Labtech社は、当社独自の方法による

P波自動検出と心房細動自動解析手法

T Wave Alternans 解析手法を開発し、当社ホルターに搭載。

VectraCardiology,Heart Rate Variability
TWA オルタナンス Turbulence、3D可変表示、
Spectral Analysis,等が装備

ケアテイカ

非観血相対血圧・連続・ポータブル・ウエアラブル・一拍毎解析出力付き

httpswww.ncbi.nlm.nih.govpmcarticlesPMC5361833

 

BMC Anesthesiol. 2017; 17: 48.

Published online 2017 Mar 21. doi: 10.1186/s12871-017-0337-z

PMCID: PMC5361833

PMID: 28327093

Continuous Non-invasive finger cuff CareTaker® comparable to invasive intra-arterial pressure in patients undergoing major intra-abdominal surgery

Irwin Gratz,1 Edward Deal,1 Francis Spitz,1 Martin Baruch,2 I. Elaine Allen,3 Julia E. Seaman,4 Erin Pukenas,1 and Smith Jean1

Author information Article notes Copyright and License information Disclaimer

This article has been cited by other articles in PMC.

 

Associated Data

Data Availability Statement

The datasets generated during and analysed for the current study are available from the corresponding author on reasonable request.

 

Abstract

Background

Despite increased interest in non-invasive arterial pressure monitoring, the majority of commercially available technologies have failed to satisfy the limits established for the validation of automatic arterial pressure monitoring by the Association for the Advancement of Medical Instrumentation (AAMI). According to the ANSI/AAMI/ISO 81060–2:2013 standards, the group-average accuracy and precision are defined as acceptable if bias is not greater than 5 mmHg and standard deviation is not greater than 8 mmHg. In this study, these standards are used to evaluate the CareTaker® (CT) device, a device measuring continuous non-invasive blood pressure via a pulse contour algorithm called Pulse Decomposition Analysis.

Methods

A convenience sample of 24 patients scheduled for major abdominal surgery were consented to participate in this IRB approved pilot study. Each patient was monitored with a radial arterial catheter and CT using a finger cuff applied to the contralateral thumb. Hemodynamic variables were measured and analyzed from both devices for the first thirty minutes of the surgical procedure including the induction of anesthesia. The mean arterial pressure (MAP), systolic and diastolic blood pressures continuously collected from the arterial catheter and CT were compared. Pearson correlation coefficients were calculated between arterial catheter and CT blood pressure measurements, a Bland-Altman analysis, and polar and 4Q plots were created.

Results

The correlation of systolic, diastolic, and mean arterial pressures were 0.92, 0.86, 0.91, respectively (p<0.0001 for all the comparisons). The Bland-Altman comparison yielded a bias (as measured by overall mean difference) of −0.57, −2.52, 1.01 mmHg for systolic, diastolic, and mean arterial pressures, respectively with a standard deviation of 7.34, 6.47, 5.33 mmHg for systolic, diastolic, and mean arterial pressures, respectively (p<0.001 for all comparisons). The polar plot indicates little bias between the two methods (90%/95% CI at 31.5°/52°, respectively, overall bias=1.5°) with only a small percentage of points outside these lines. The 4Q plot indicates good concordance and no bias between the methods.

Conclusions

In this study, blood pressure measured using the non-invasive CT device was shown to correlate well with the arterial catheter measurements. Larger studies are needed to confirm these results in more varied settings. Most patients exhibited very good agreement between methods. Results were well within the limits established for the validation of automatic arterial pressure monitoring by the AAMI.

Keywords: Non-Invasive, CareTaker, Central blood pressure, Finger cuff, Intra-Arterial pressure


Tensiomed 社 Arteriograph 24 血管脈波検査装置

ご注意:中心血圧と関連機能は検証が必要です、

Central blood pressure: current evidence

and clinical importance

Carmel M. McEniery1*, John R. Cockcroft2, Mary J. Roman3,

Stanley S. Franklin4, and Ian B.Wilkinson1

1Clinical Pharmacology Unit, University of Cambridge, Addenbrookes Hospital, Box 110, Cambridge CB22QQ, UK; 2Department of Cardiology,Wales Heart Research Institute, Cardiff

CF14 4XN, UK; 3Division of Cardiology,Weill Cornell Medical College, New York, NY 10021, USA; and 4University of California, UCI School of Medicine, Irvine, CA 92697-4101, USA

Received 29 April 2013; revised 27 November 2013; accepted 17 December 2013; online publish-ahead-of-print 23 January 2014

and central pressure. Therefore, basing treatment decisions on central, rather than brachial pressure, is likely to have important implications

for the future diagnosis and management of hypertension. Such a paradigm shift will, however, require further, direct evidence that selectively

targeting central pressure, brings added benefit, over and above that already provided by brachial artery pressure.

Central pressure Blood pressure Anti-hypertensive treatment Cardiovascular risk

Introduction

The brachial cuff sphygmomanometer was introduced into medical

practice well over 100 years ago, enabling the routine, non-invasive,

measurement of arterial blood pressure. Life insurance companies

were among the first to capitalize on the information provided by

cuff sphygmomanometry, by observing that blood pressure in

largely asymptomatic individuals relates to future cardiovascular

riskobservations that are nowsupported by a wealth of epidemiological

data.1 The most recent Global Burden of Disease report2

identified hypertension as the leading cause of death and disability

worldwide. Moreover, data from over 50 years of randomized controlled

trials clearly demonstrate that lowering brachial pressure,

in hypertensive individuals, substantially reduces cardiovascular

events.1,3 For these reasons, measurement of brachial blood pressure

has become embedded in routine clinical assessment throughout the

developed world, and is one of the most widely accepted surrogate

measures for regulatory bodies.

The major driving force for the continued use of brachial blood

pressure has been its ease of measurement, and the wide variety of

devices available for clinical use. However, we have known for over

half a century that brachial pressure is a poor surrogate for aortic

pressure, which is invariably lower than corresponding brachial

values. Recent evidence suggests that central pressure is also more

strongly related to future cardiovascular events4 7 than brachial

pressure, and responds differently to certain drugs.8,9 Appreciating

this provides an ideal framework for understanding the much publicized

inferiority of atenolol and some other beta-blockers,10 compared

with other drug classes, in the management of essential

hypertension. Although central pressure can now be assessed noninvasively

with the same ease as brachial pressure, clinicians are unlikely

to discard the brachial cuff sphygmomanometer without

robust evidence that cardiovascular risk stratification, and monitoring

response to therapy, are better when based on central rather

than peripheral pressure. Central pressure assessment and accuracy

will also have to be standardized, as it has been for brachial pressure

assessment with oscillometric devices. This review will discuss our

current understanding about central pressure and the evidence

required to bring blood pressure measurement, and cardiovascular

risk assessment into the modern era.

Physiological concepts

Arterial pressure varies continuously over the cardiac cycle, but in

clinical practice only systolic and diastolic pressures are routinely

reported. These are invariably measured in the brachial artery

using cuff sphygmomanometrya practice that has changed little

over the last century. However, the shape of the pressure waveform

* Corresponding author. Tel: +44 1223 336806, Fax: +44 1223 216893, Email: cmm41@cam.ac.uk

Published on behalf of the European Society of Cardiology. All rights reserved. &The Author 2014. For permissions please email: journals.permissions@oup.com

European Heart Journal (2014) 35, 17191725 doi:10.1093/eurheartj/eht565

 

Pressure measured with a cuff and sphygmomanometer in the brachial artery is accepted as an important predictor of future cardiovascular risk.However, systolic pressure varies throughout the arterial tree, such that aortic (central) systolic pressure is actually lower than corresponding brachial values, although this difference is highly variable between individuals. Emerging evidence now suggests that central pressure is better related to future cardiovascular events than is brachial pressure. Moreover, anti-hypertensive drugs can exert differential effects on brachial and central pressure. Therefore, basing treatment decisions on central, rather than brachial pressure, is likely to have important implications for the future diagnosis and management of hypertension. Such a paradigm shift will, however, require further, direct evidence that selectively targeting central pressure, brings added benefit, over and above that already provided by brachial artery pressure.As discussed earlier, a full synthesis of the available evidence concerning

central pressure and the risk of future cardiovascular events is now required. However, it will also be necessary to determine the clinical relevance of differences between brachial and central pressure

for the individual patient, especially given the relatively high correlation between the two. Emerging data support the prognostic superiority of both 24-h ambulatory blood pressure monitoring

(ABPM)79 81 andhomemonitoring81 in comparison with office measurements. Interestingly, a recent study82 demonstrated that 24-h ambulatory cuff pressures were comparable with office central pressure

measurements in the prediction of risk, although the significance of this study awaits confirmation.83 As yet, there are no data comparing the predictive value ofhomemonitoring vs. central pressure in the

prediction of risk. Ultimately, it will be necessary to evaluate the prognostic value of 24-h ambulatory central pressure.With the recent development of ambulatory central pressure systems,84,85 this is now

possible and it may be reasonable to hypothesize that 24-h central, rather than brachial ABPM would be superior in terms of risk prediction.

アルテリオグラフの中心血圧測定 中心血検証をお願いします アルテリオグラフの文献例 オーグメンテイション
血管解析ソフト スマホ遠隔画像表示 ポータブルCT Airstrip社画像例
心電図三次元解析 心筋画像化解析 心臓用ジャケット 超電磁式心臓画像
冠動脈疾患図解 DICOM画像管理 心電図解析 心電図解析ー研究テーマ
gTec高級解析ソフトの心電RR解析 組織飽和酸素 スペクトロ分析 レーザ血流画像
電気生理マッピング MRI/CT画像セグメント化 MRI下生体モニタ 冠動脈内解説
パルスオキシの心房細動 冠動脈内サーモグラフィ フレイルティメータ
先天性心疾患ソフト Pedcath7 Pedcath8 川崎病
Pedcath概要 Pedcathの本 Pedcathの仲間 Pedcath選定理由書
Pedcath参考画像 Pedcath品目 Pedcathマルティユーザ Pedcath拡張機能
佐野シャント ペドカスコンパニオン タブレット補助Pedcath
心肺自動蘇生 重症患者用ストレッチャ 介護支援用具 ハンディエコークラリウス
パソコン式呼吸機能測定 インプラント医療機器 災害訓練用機材 音波血栓除去
保温パッド 自在アーム ハンディスコープ ミニマルインベイシブ
心不全 電磁式植込連続血圧監視 感染などの環境 胸骨薬液注入
救命救急搬送器 IVの遠隔監視 モバイルスパイロメータ 心筋還流改善の一方法
パソコン式肺機能検査 血管内温度制御 心血管代謝不全治療 肺機能補助
補助人工心臓tandem 新しい心不全救命 マイクロIABP 体温制御ジャケット
パソコンに通信機能 インターネット式電子カルテ サーマルペーパ ウエアラブル生体監視
マイクロ・ワイヤレス・ネット対応多種類センサー オープンドルフィン 医療用ロボット 医療用オンラインソフト
カルディオスター カルディオスター心電図 カルディオスター循環器 カルディオスター概要
メンネンメディカル ウエアラブル12誘導心電図電極 西陣織12誘導心電図電極 ワンタッチ心電図電極
ウエアラブルモバイル心電図 眼鏡にPC画面表示 SHARPロボット ShimmerSensingにLabview
ウエアラブル式胸部12誘導心電図 多種類センサー式ワイヤレスアンプ ワイヤレス用USB ウエアラブルの米国例
ウエアラブル米国例 第三回2017ウエアラブル展より ウエアラブルセンサー例 第二回2016ウエアラブル展より
スマートめがね ウエアラブル用素材 スマホ装着生体プリアンプ
ヘモグロビンモニター 地中海病治療用具 採血用具 ルーペ
ICG検査 インプラント骨固定器 マイクロダイアリシス マイクロルーメン
小型モータ マイクロポンプ ヘモグロビン検査 PO2センサ
ラブテックホルタ心電計 ラブテックホルタ心電計資料 ワイヤレスブルーツース100mの例 カルディオビューとテレバイタル
中心血検証をお願いします アルテリオグラフの文献例 薬液注入 カルディオビューパンフレット
先天性心疾患ソフト 画像表示付き聴診器 タイマ無し出力付き研究電子聴診器 カルディオニクス製製品
メディカルテクニカ掲示板 メディカルテクニカ掲示板 リンク リンク
ケアテイカメディカル ケアテイカ ケアテイカ 血圧制御
MRI下非観血連続血圧計 ケアテイカ案内 ケアテイカのカフの位置
カルディオビューによる心電図マネイジメント カルディオビューの邦文不整脈用語対照表 カルディオビューの不整脈解析精度 カルディオビューパンフレット
パラマ・テック1チャンネル長時間記憶心電計 心電計の種類 カルディオビュー画面例 遠隔12誘導心電図オンライン同時表示
テレバイタル遠隔診療 救命救急時の遠隔12誘導心電図波形表示 テレバイタル心電図以外のパラメータ 遠隔ICUへの応用
遠隔離島などの応用例 カルディオビューとテレバイタル テレバイタル総合システム例 テレバイタルにビデオ付き
テレバイタル基本部バイタルウエア テレバイタル例
ラブテック社心臓リハビリ メタボリックテスト ラブテック社ワイヤレス12誘導心電計 ラブテック社12誘導心電計
ラブテック12誘導心電計 心電図解析 ラブテック社モバイル心電計 検診用心電計
ラブテックホルタ心電計 ラブテックホルタ心電計 ラブテックホルタ心電計 ラブテックホルタ心電計
ラブテックホルタ心電計 ラブテックネット心電図 シムレータ
ラブテック社心臓リハビリ
ラブテックホルタ心電計資料
心臓リハビリ12誘導心電計 タブレットの12誘導心電図での利用例
ワイヤレスブルーツース100mの例
米国遠隔医療機器 12誘導心電図電極 自動遠隔虚血補助器 遠隔睡眠解析
在宅糖尿病監視 遠隔無呼吸症監視 12誘導心電図電極 耳より生体信号
飛行機内などの遠隔心電図診断 在宅生体信号監視 国産心電図ケーブル 無呼吸監視
ディスポ型12誘導心電図電極 在宅医療 呼吸と心拍の遠隔監視 心音付き心電図
心電図等のケーブル類 遠隔医療多機能モニタ 多機能センサー 見守りレーダ
遠隔12誘導心電図試験 遠隔診断用椅子 簡易心電図電極式遠隔診断 WiMAX回線の遠隔診断
ベッドの漏れ検出